Chang David J. 4
4 · Cabaletta Bio, Inc. · Filed Mar 2, 2021
Insider Transaction Report
Form 4
Chang David J.
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-03-01+113,500→ 113,500 totalExercise: $11.47Exp: 2031-02-28→ Common Stock (113,500 underlying)
Footnotes (1)
- [F1]This option vests over four years, with 25% vesting on March 1, 2022 and the remaining shares vesting in 12 equal quarterly installments thereafter.